| RFA-HG-21-029 |
See Related
|
NHGRI |
08/06/2021 |
10/01/2021
|
11/02/2021
|
UM1
|
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1: Data Production Research and Development Centers (UM1)(Clinical trials not allowed) |
| RFA-HG-21-031 |
See Related
|
NHGRI |
08/06/2021 |
10/01/2021
|
11/02/2021
|
U24
|
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U24 Clinical trials not allowed) |
| RFA-HG-21-030 |
See Related
|
NHGRI |
08/06/2021 |
10/01/2021
|
11/02/2021
|
U01
|
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed) |
| RFA-NS-22-001 |
See Related
|
NINDS |
08/06/2021 |
09/22/2021
|
11/23/2021
|
U01
|
Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed) |
| RFA-HG-21-041 |
See Related
|
NHGRI |
08/05/2021 |
01/22/2022
|
02/23/2024
|
R01
|
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) |
| RFA-DK-21-010 |
See Related
|
NIDDK |
08/04/2021 |
09/20/2021
|
10/21/2021
|
U24
|
Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed) |
| RFA-CA-21-052 |
See Related
|
NCI |
08/03/2021 |
10/01/2021
|
11/02/2021
|
U54
|
Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed) |
| RFA-CA-21-053 |
See Related
|
NCI |
08/03/2021 |
10/01/2021
|
11/02/2021
|
U24
|
Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed) |
| RFA-HG-21-033 |
See Related
|
NHGRI |
08/03/2021 |
11/01/2021
|
07/02/2023
|
R25
|
Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed) |
| RFA-NS-22-006 |
See Related
|
NINDS |
08/02/2021 |
09/26/2021
|
10/27/2021
|
R01
|
Leveraging Existing Data Resources for Computational Model and Tool Development to Discover Novel Candidate Mechanisms and Biomarkers for ADRD (R01 Clinical Trial Not Allowed) |
| RFA-DA-22-023 |
See Related
|
NIDA |
07/29/2021 |
01/18/2022
|
02/19/2022
|
R43/R44
|
Advancing Validated Drug Targets for Substance Use Disorders (R43/R44 - Clinical Trial Not Allowed) |
| RFA-DA-22-018 |
See Related
|
NIDA |
07/29/2021 |
01/18/2022
|
02/19/2022
|
R41/R42
|
Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed) |
| RFA-CA-21-049 |
See Related
|
NCI |
07/29/2021 |
10/12/2021
|
11/13/2021
|
U24
|
Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed) |
| RFA-CA-21-048 |
See Related
|
NCI |
07/28/2021 |
10/12/2021
|
10/20/2022
|
U54
|
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) |
| RFA-DK-21-018 |
See Related
|
NIDDK |
07/28/2021 |
02/03/2022
|
03/04/2022
|
R01
|
Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required) |
| RFA-MH-21-237 |
See Related
|
NIMH |
07/27/2021 |
10/09/2021
|
11/10/2021
|
U24
|
BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed) |
| RFA-MH-21-236 |
See Related
|
NIMH |
07/27/2021 |
10/09/2021
|
11/10/2021
|
U01
|
BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed) |
| RFA-MH-21-235 |
See Related
|
NIMH |
07/27/2021 |
10/09/2021
|
11/10/2021
|
UM1
|
BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed) |
| RFA-CA-21-050 |
See Related
|
NCI |
07/27/2021 |
08/27/2021
|
09/28/2021
|
U01
|
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) |
| RFA-CA-21-051 |
See Related
|
NCI |
07/27/2021 |
08/27/2021
|
09/28/2021
|
U24
|
Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed) |
| RFA-NS-21-033 |
See Related
|
NINDS |
07/27/2021 |
09/21/2021
|
10/11/2023
|
UE5
|
Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed) |
| RFA-CA-21-042 |
See Related
|
NCI |
07/26/2021 |
10/01/2021
|
11/02/2021
|
U24
|
Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed) |
| RFA-CA-21-041 |
See Related
|
NCI |
07/26/2021 |
10/01/2021
|
11/02/2021
|
U01
|
Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed) |
| RFA-AG-22-023 |
See Related
|
NIA |
07/22/2021 |
09/28/2021
|
10/29/2021
|
U24
|
Limited Competition: Data Management and Coordinating Center (DMCC) and a Collaborative Research Space for Translational Research on Exceptional Longevity (U24 Clinical Trial Not Allowed) |
| RFA-DA-22-033 |
See Related
|
NIDA |
07/22/2021 |
01/17/2022
|
02/18/2022
|
U24
|
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) |
| RFA-AG-22-024 |
See Related
|
NIA |
07/15/2021 |
09/20/2021
|
10/21/2021
|
R61/R33
|
Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) |
| RFA-CA-21-038 |
See Related
|
NCI |
07/15/2021 |
09/07/2021
|
10/08/2021
|
U54
|
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) |
| RFA-CA-21-039 |
See Related
|
NCI |
07/15/2021 |
09/07/2021
|
10/08/2021
|
U24
|
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed) |
| RFA-AG-22-015 |
See Related
|
NIA |
07/15/2021 |
09/20/2021
|
10/21/2021
|
R61/R33
|
Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed) |
| RFA-MH-21-205 |
See Related
|
NIMH |
07/14/2021 |
09/13/2021
|
10/12/2023
|
R01
|
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) |
| RFA-DK-21-003 |
See Related
|
NIDDK |
07/14/2021 |
02/03/2022
|
03/04/2022
|
U01
|
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed) |
| RFA-DK-21-002 |
See Related
|
NIDDK |
07/14/2021 |
02/03/2022
|
03/04/2022
|
U01
|
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed) |
| RFA-DK-21-013 |
See Related
|
NIDDK |
07/14/2021 |
09/20/2021
|
10/21/2021
|
U01
|
Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed) |
| RFA-AG-22-021 |
See Related
|
NIA |
07/14/2021 |
10/02/2021
|
11/03/2021
|
R01
|
Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed) |
| RFA-HL-22-014 |
See Related
|
NHLBI |
07/13/2021 |
09/08/2021
|
10/09/2021
|
UG3/UH3
|
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) |
| RFA-LM-21-002 |
See Related
|
NLM |
07/12/2021 |
08/17/2021
|
09/18/2021
|
U24
|
Network of the National Library of Medicine All of Us Program Center (U24) (Clinical Trial Optional) |
| RFA-RM-21-025 |
See Related
|
RMOD |
07/12/2021 |
08/24/2021
|
09/25/2021
|
U54
|
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) |
| RFA-AI-21-050 |
See Related
|
NIAID |
07/09/2021 |
09/22/2021
|
10/23/2021
|
U19
|
Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) |
| RFA-HG-21-001 |
See Related
|
NHGRI |
07/09/2021 |
10/01/2021
|
06/16/2023
|
R01
|
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
| RFA-HG-21-002 |
See Related
|
NHGRI |
07/09/2021 |
09/01/2021
|
06/16/2023
|
R21
|
Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) |
| RFA-DA-23-001 |
See Related
|
NIDA |
07/08/2021 |
07/11/2022
|
08/12/2022
|
R61/R33
|
Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) |
| RFA-AI-21-041 |
See Related
|
NIAID |
07/07/2021 |
11/06/2021
|
12/07/2021
|
R21
|
Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed) |
| RFA-DK-21-014 |
See Related
|
NIDDK |
07/06/2021 |
09/20/2021
|
10/21/2021
|
U24
|
Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (U24 Clinical Trial Not Allowed) |
| RFA-DA-22-020 |
See Related
|
NIDA |
07/06/2021 |
10/18/2021
|
11/19/2021
|
R25
|
Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers (UE5 Clinical Trial Not Allowed) |
| RFA-CA-21-021 |
See Related
|
NCI |
07/06/2021 |
09/06/2021
|
10/07/2021
|
U01
|
Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional) |
| RFA-CA-21-022 |
See Related
|
NCI |
07/06/2021 |
09/06/2021
|
10/07/2021
|
U24
|
Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed) |
| RFA-AG-22-027 |
See Related
|
NIA |
07/06/2021 |
10/02/2021
|
11/03/2021
|
R03
|
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) |
| RFA-AG-22-022 |
See Related
|
NIA |
07/06/2021 |
09/28/2021
|
10/29/2021
|
R21/R33
|
Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) |
| RFA-DA-22-031 |
See Related
|
NIDA |
07/06/2021 |
09/19/2021
|
10/20/2021
|
R01
|
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) |
| RFA-DA-22-032 |
See Related
|
NIDA |
07/06/2021 |
09/19/2021
|
10/20/2021
|
R21
|
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) |
| RFA-DE-22-003 |
See Related
|
NIDCR |
06/29/2021 |
10/18/2021
|
11/19/2021
|
R01
|
Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed) |
| RFA-DA-22-029 |
See Related
|
NIDA |
06/28/2021 |
09/14/2021
|
10/15/2021
|
R61/R33
|
Exploratory Studies to Investigate the Mechanisms of Interrelationship between Sleep and Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required) |
| RFA-DE-22-004 |
See Related
|
NIDCR |
06/28/2021 |
10/18/2021
|
11/19/2021
|
R21
|
Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed) |
| RFA-CA-21-026 |
See Related
|
NCI |
06/25/2021 |
09/08/2021
|
10/09/2021
|
R01
|
Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional) |
| RFA-CA-21-027 |
See Related
|
NCI |
06/25/2021 |
09/08/2021
|
10/09/2021
|
U24
|
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed) |
| RFA-MH-21-241 |
See Related
|
NIMH |
06/25/2021 |
10/09/2021
|
11/10/2021
|
R34
|
Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required) |
| RFA-MH-21-240 |
See Related
|
NIMH |
06/25/2021 |
10/08/2021
|
11/10/2021
|
R01
|
Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required) |
| RFA-ES-21-006 |
See Related
|
NIEHS |
06/25/2021 |
09/14/2021
|
09/21/2023
|
R01
|
CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed) |
| RFA-DC-22-001 |
See Related
|
NIDCD |
06/25/2021 |
09/17/2021
|
06/21/2024
|
R01
|
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) |
| RFA-DK-21-021 |
See Related
|
NIDDK |
06/25/2021 |
01/17/2022
|
10/08/2022
|
R43/R44
|
Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) |
| RFA-CA-21-040 |
See Related
|
NCI |
06/24/2021 |
10/01/2021
|
11/02/2021
|
U54
|
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) |
| RFA-DA-22-003 |
See Related
|
NIDA |
06/23/2021 |
01/02/2022
|
02/03/2022
|
R01
|
Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed) |
| RFA-AG-22-025 |
See Related
|
NIA |
06/23/2021 |
09/20/2021
|
10/21/2021
|
R01
|
Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed) |
| RFA-DA-22-011 |
See Related
|
NIDA |
06/21/2021 |
09/15/2021
|
10/16/2021
|
R01
|
Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed) |
| RFA-DA-22-009 |
See Related
|
NIDA |
06/17/2021 |
10/17/2021
|
11/18/2021
|
R01
|
Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional) |
| RFA-AG-22-018 |
See Related
|
NIA |
06/17/2021 |
09/28/2021
|
10/29/2021
|
R01
|
Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed) |
| RFA-HL-22-012 |
See Related
|
NHLBI |
06/17/2021 |
07/09/2021
|
02/24/2024
|
R25
|
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed) |
| RFA-DA-22-017 |
See Related
|
NIDA |
06/16/2021 |
10/12/2021
|
11/13/2021
|
R01
|
PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) |
| RFA-AG-22-017 |
See Related
|
NIA |
06/16/2021 |
09/28/2021
|
10/29/2021
|
R01
|
Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) |
| RFA-AI-20-069 |
See Related
|
NIAID |
06/15/2021 |
09/13/2021
|
10/14/2021
|
R61/R33
|
Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional) |
| RFA-AI-21-046 |
See Related
|
NIAID |
06/10/2021 |
09/22/2021
|
10/23/2021
|
R01
|
Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed) |
| RFA-AG-22-019 |
See Related
|
NIA |
06/10/2021 |
09/28/2021
|
10/29/2021
|
R01
|
High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) |
| RFA-AG-22-014 |
See Related
|
NIA |
06/10/2021 |
09/26/2021
|
10/27/2021
|
R41/R42
|
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) |
| RFA-AG-22-007 |
See Related
|
NIA |
06/10/2021 |
09/26/2021
|
10/27/2021
|
R43/R44
|
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) |
| RFA-AG-22-004 |
See Related
|
NIA |
06/10/2021 |
08/29/2021
|
09/30/2021
|
K01
|
NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) |
| RFA-AG-22-003 |
See Related
|
NIA |
06/10/2021 |
09/04/2021
|
10/05/2021
|
R25
|
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed) |
| RFA-RM-21-023 |
See Related
|
RMOD |
06/08/2021 |
07/20/2021
|
08/21/2021
|
U54
|
Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed) |
| RFA-NS-21-027 |
See Related
|
NINDS |
06/08/2021 |
09/29/2021
|
10/28/2023
|
U01
|
BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) |
| RFA-NS-21-026 |
See Related
|
NINDS |
06/08/2021 |
09/29/2021
|
10/28/2023
|
R01
|
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) |
| RFA-NS-21-029 |
See Related
|
NINDS |
06/08/2021 |
06/19/2021
|
10/11/2023
|
R61
|
HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) |
| RFA-AA-21-009 |
See Related
|
NIAAA |
06/04/2021 |
07/16/2021
|
08/19/2021
|
U24
|
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional) |
| RFA-AA-21-007 |
See Related
|
NIAAA |
06/04/2021 |
07/18/2021
|
08/19/2021
|
U01
|
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional) |
| RFA-AA-21-008 |
See Related
|
NIAAA |
06/04/2021 |
07/18/2021
|
08/19/2021
|
U24
|
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional) |
| RFA-RM-21-017 |
See Related
|
RMOD |
06/04/2021 |
08/02/2021
|
09/02/2021
|
R01
|
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) |
| RFA-DA-22-016 |
See Related
|
NIDA |
06/04/2021 |
09/14/2021
|
10/15/2021
|
R61/R33
|
Exploratory Studies to Investigate the Mechanisms of Interrelationship Between Sleep and Substance Use Disorders (R61/R33 Clinical Trials Not Allowed) |
| RFA-DK-21-016 |
See Related
|
NIDDK |
06/03/2021 |
10/03/2021
|
11/04/2021
|
R01
|
Characterization of Islet-derived Extracellular Vesicles for Improved Detection, Monitoring, Classification, and Treatment of Type 1 Diabetes (R01 Clinical Trial Not Allowed) |
| RFA-AA-21-014 |
See Related
|
NIAAA |
06/02/2021 |
07/16/2021
|
08/17/2021
|
UH2
|
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional) |
| RFA-AA-21-013 |
See Related
|
NIAAA |
06/02/2021 |
07/16/2021
|
08/17/2021
|
U24
|
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Resource (U24 Clinical Trial Not Allowed) |
| RFA-AA-21-012 |
See Related
|
NIAAA |
06/02/2021 |
07/16/2021
|
08/17/2021
|
U24
|
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Resource (U24 Clinical Trial Not Allowed) |
| RFA-AA-21-011 |
See Related
|
NIAAA |
06/02/2021 |
07/16/2021
|
08/17/2021
|
U24
|
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Resource (U24) (Clinical Trial Not Allowed) |
| RFA-AA-21-010 |
See Related
|
NIAAA |
06/02/2021 |
07/16/2021
|
08/17/2021
|
U01
|
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional) |
| RFA-CA-21-035 |
See Related
|
NCI |
06/01/2021 |
08/09/2021
|
09/10/2021
|
U2C
|
The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) |
| RFA-CA-21-034 |
See Related
|
NCI |
06/01/2021 |
08/09/2021
|
09/10/2021
|
U24
|
The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed) |
| RFA-CA-21-033 |
See Related
|
NCI |
06/01/2021 |
08/09/2021
|
09/10/2021
|
U01
|
The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) |
| RFA-HL-22-011 |
See Related
|
NHLBI |
05/26/2021 |
09/14/2021
|
05/08/2024
|
K01
|
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) |
| RFA-HL-22-010 |
See Related
|
NHLBI |
05/25/2021 |
09/14/2021
|
05/08/2024
|
K01
|
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) |
| RFA-MH-21-226 |
See Related
|
NIMH |
05/24/2021 |
07/27/2021
|
08/28/2021
|
R21
|
Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R21 Clinical Trial Optional) |
| RFA-MH-21-225 |
See Related
|
NIMH |
05/24/2021 |
07/27/2021
|
08/28/2021
|
R01
|
Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R01 Clinical Trial Optional) |
| RFA-DA-22-030 |
See Related
|
NIDA |
05/24/2021 |
09/14/2021
|
10/15/2021
|
R21
|
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required) |
| RFA-DA-22-024 |
See Related
|
NIDA |
05/24/2021 |
09/14/2021
|
10/15/2021
|
R01
|
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required) |
| RFA-DA-22-007 |
See Related
|
NIDA |
05/24/2021 |
09/14/2021
|
10/15/2021
|
R01
|
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) |
| RFA-DA-22-005 |
See Related
|
NIDA |
05/24/2021 |
09/14/2021
|
10/15/2021
|
R21
|
Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) |
| RFA-RM-21-016 |
See Related
|
RMOD |
05/20/2021 |
07/20/2021
|
08/21/2021
|
DP2
|
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) |
| RFA-TW-21-004 |
See Related
|
FIC |
05/19/2021 |
07/20/2021
|
08/21/2021
|
D43
|
Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional) |
| RFA-DK-21-012 |
See Related
|
NIDDK |
05/19/2021 |
02/09/2022
|
10/08/2022
|
R43/R44
|
Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) |
| RFA-HL-22-001 |
See Related
|
NHLBI |
05/11/2021 |
08/13/2021
|
02/29/2024
|
T32
|
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) |
| RFA-AI-21-016 |
See Related
|
NIAID |
05/11/2021 |
08/03/2021
|
09/04/2021
|
U01
|
Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed) |
| RFA-DK-21-007 |
See Related
|
NIDDK |
05/07/2021 |
09/20/2021
|
10/21/2021
|
U01
|
Standardization of C-Peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed) |
| RFA-NS-21-024 |
See Related
|
NINDS |
05/07/2021 |
06/01/2021
|
02/21/2024
|
UH3
|
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) |
| RFA-NS-21-023 |
See Related
|
NINDS |
05/07/2021 |
06/01/2021
|
02/21/2024
|
UG3/UH3
|
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
| RFA-DK-21-011 |
See Related
|
NIDDK |
05/06/2021 |
02/09/2022
|
10/08/2022
|
R43/R44
|
Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed) |
| RFA-HL-23-005 |
See Related
|
NHLBI |
05/05/2021 |
01/15/2022
|
04/26/2024
|
R35
|
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) |
| RFA-HL-23-004 |
See Related
|
NHLBI |
05/05/2021 |
01/15/2022
|
04/26/2024
|
R35
|
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) |
| RFA-HD-22-020 |
See Related
|
NICHD |
05/05/2021 |
10/29/2021
|
11/30/2021
|
R01
|
Human Milk as a Biological System (R01 Clinical Trial Optional) |
| RFA-DK-21-023 |
See Related
|
NIDDK |
04/29/2021 |
08/01/2021
|
09/02/2021
|
R25
|
NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed) |
| RFA-NS-21-022 |
See Related
|
NINDS |
04/28/2021 |
06/01/2021
|
02/21/2024
|
U44
|
Translational Neural Devices (U44 Clinical Trial Optional) |
| RFA-NS-21-021 |
See Related
|
NINDS |
04/28/2021 |
06/01/2021
|
02/21/2024
|
UG3/UH3
|
Translational Neural Devices (UG3/UH3 - Clinical Trial Optional) |
| RFA-MH-21-175 |
See Related
|
NIMH |
04/27/2021 |
09/08/2021
|
10/07/2023
|
R01
|
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) |
| RFA-DA-22-001 |
See Related
|
NIDA |
04/27/2021 |
07/13/2021
|
08/14/2021
|
R43/R44
|
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) |
| RFA-AI-21-017 |
See Related
|
NIAID |
04/27/2021 |
08/08/2021
|
09/09/2021
|
R01
|
Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed) |
| RFA-RM-21-018 |
See Related
|
RMOD |
04/26/2021 |
08/03/2021
|
09/04/2021
|
DP5
|
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) |
| RFA-DK-20-026 |
See Related
|
NIDDK |
04/22/2021 |
08/23/2021
|
09/24/2021
|
U01
|
Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed) |
| RFA-DK-20-027 |
See Related
|
NIDDK |
04/22/2021 |
08/23/2021
|
09/24/2021
|
U01
|
Kidney Precision Medicine Project Kidney Tissue Atlas Coordinating Center (U01 Clinical Trial Not Allowed) |
| RFA-DK-20-028 |
See Related
|
NIDDK |
04/22/2021 |
08/23/2021
|
09/24/2021
|
U01
|
Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed) |
| RFA-DK-20-029 |
See Related
|
NIDDK |
04/22/2021 |
08/23/2021
|
09/24/2021
|
U24
|
Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed) |
| RFA-NS-21-012 |
See Related
|
NINDS |
04/21/2021 |
11/15/2021
|
12/16/2023
|
F99/K00
|
NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) |
| RFA-AI-21-030 |
See Related
|
NIAID |
04/20/2021 |
09/13/2021
|
10/14/2021
|
U54
|
Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed) |
| RFA-MH-21-230 |
See Related
|
NIMH |
04/19/2021 |
06/01/2021
|
03/02/2022
|
R34
|
Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required) |
| RFA-CA-21-037 |
See Related
|
NCI |
04/14/2021 |
05/30/2021
|
11/23/2021
|
UH2
|
3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed) |
| RFA-DA-22-021 |
See Related
|
NIDA |
04/08/2021 |
07/10/2021
|
08/11/2021
|
R41/R42
|
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed) |
| RFA-DA-22-019 |
See Related
|
NIDA |
04/08/2021 |
07/10/2021
|
08/11/2021
|
R43/R44
|
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed) |
| RFA-MH-21-180 |
See Related
|
NIMH |
04/08/2021 |
10/23/2021
|
07/13/2022
|
U24
|
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) |
| RFA-RM-21-015 |
See Related
|
RMOD |
04/06/2021 |
08/10/2021
|
09/11/2021
|
DP1
|
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) |
| RFA-DK-21-006 |
See Related
|
NIDDK |
04/06/2021 |
09/20/2021
|
10/21/2021
|
R01
|
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) |
| RFA-AG-22-016 |
See Related
|
NIA |
04/06/2021 |
08/15/2021
|
09/16/2021
|
R61/R33
|
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required) |
| RFA-NS-21-014 |
See Related
|
NINDS |
04/05/2021 |
06/07/2021
|
11/11/2021
|
R34
|
BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) |
| RFA-NS-21-013 |
See Related
|
NINDS |
04/05/2021 |
06/07/2021
|
11/11/2021
|
R01
|
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) |
| RFA-AA-21-006 |
See Related
|
NIAAA |
04/05/2021 |
10/15/2021
|
11/16/2021
|
P60
|
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) |
| RFA-AA-21-005 |
See Related
|
NIAAA |
04/05/2021 |
10/15/2021
|
11/16/2021
|
P50
|
Specialized Alcohol Research Centers (P50 Clinical Trial Optional) |
| RFA-DK-21-501 |
See Related
|
NIDDK |
04/05/2021 |
07/17/2021
|
08/18/2021
|
U01
|
Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional) |
| RFA-AI-21-019 |
See Related
|
NIAID |
04/02/2021 |
07/24/2021
|
08/25/2021
|
U01
|
Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed) |
| RFA-HG-21-007 |
See Related
|
NHGRI |
03/30/2021 |
05/26/2021
|
02/02/2023
|
R21
|
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed) |
| RFA-HG-21-006 |
See Related
|
NHGRI |
03/30/2021 |
05/26/2021
|
02/02/2023
|
R01
|
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) |
| RFA-HG-21-008 |
See Related
|
NHGRI |
03/30/2021 |
05/26/2021
|
02/02/2023
|
R43/R44
|
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) |
| RFA-DK-21-015 |
See Related
|
NIDDK |
03/29/2021 |
09/20/2021
|
10/21/2021
|
P30
|
Nutrition Obesity Research Centers (P30 Clinical Trial Optional) |
| RFA-MD-21-004 |
See Related
|
NIMHD |
03/23/2021 |
07/20/2021
|
08/25/2021
|
R01
|
Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional) |
| RFA-AG-22-009 |
See Related
|
NIA |
03/23/2021 |
09/04/2021
|
10/05/2021
|
R25
|
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed) |
| RFA-AG-22-010 |
See Related
|
NIA |
03/23/2021 |
09/04/2021
|
10/05/2021
|
R25
|
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed) |
| RFA-AR-22-002 |
See Related
|
NIAMS |
03/19/2021 |
08/13/2021
|
09/14/2021
|
P30
|
Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed |
| RFA-AI-21-035 |
See Related
|
NIAID |
03/17/2021 |
06/02/2021
|
07/07/2023
|
R21
|
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed) |
| RFA-AI-21-021 |
See Related
|
NIAID |
03/17/2021 |
06/02/2021
|
07/07/2023
|
U24
|
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed) |
| RFA-AI-21-020 |
See Related
|
NIAID |
03/17/2021 |
06/02/2021
|
07/07/2023
|
U01
|
Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed) |
| RFA-DK-21-004 |
See Related
|
NIDDK |
03/17/2021 |
05/22/2021
|
03/10/2022
|
R01
|
The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) |
| RFA-NS-21-015 |
See Related
|
NINDS |
03/11/2021 |
03/27/2021
|
10/11/2023
|
U19
|
HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) |
| RFA-MH-21-135 |
See Related
|
NIMH |
03/10/2021 |
09/15/2021
|
06/08/2024
|
R01
|
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
| RFA-MH-21-130 |
See Related
|
NIMH |
03/10/2021 |
09/07/2021
|
10/08/2021
|
R01
|
BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
| RFA-OD-21-004 |
See Related
|
NIH |
03/10/2021 |
09/08/2021
|
03/09/2023
|
R21
|
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) |
| RFA-OD-21-003 |
See Related
|
NIH |
03/10/2021 |
09/08/2021
|
03/09/2023
|
R21
|
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
| RFA-DA-22-010 |
See Related
|
NIDA |
02/26/2021 |
09/25/2021
|
10/26/2022
|
R01
|
Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) |
| RFA-MH-21-120 |
See Related
|
NIMH |
02/23/2021 |
10/14/2021
|
12/09/2021
|
R01
|
Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional) |
| RFA-OD-21-002 |
See Related
|
NIH |
02/17/2021 |
06/14/2021
|
02/15/2023
|
R01
|
Tobacco Regulatory Science (R01 Clinical Trial Optional) |
| RFA-FD-22-001 |
See Related
|
FDA |
02/17/2021 |
12/17/2021
|
02/14/2024
|
R01
|
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required |
| RFA-AA-21-003 |
See Related
|
NIAAA |
02/05/2021 |
03/14/2021
|
08/18/2021
|
R03
|
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) |
| RFA-AA-21-002 |
See Related
|
NIAAA |
02/05/2021 |
03/14/2021
|
08/18/2021
|
R01
|
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) |
| RFA-AA-21-004 |
See Related
|
NIAAA |
02/05/2021 |
03/14/2021
|
08/18/2021
|
R21
|
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) |
| RFA-DA-22-006 |
See Related
|
NIDA |
02/04/2021 |
08/15/2021
|
09/16/2021
|
R01
|
High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) |
| RFA-DA-22-004 |
See Related
|
NIDA |
02/02/2021 |
06/14/2021
|
08/11/2022
|
R61/R33
|
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) |
| RFA-DA-22-008 |
See Related
|
NIDA |
01/25/2021 |
08/15/2021
|
09/16/2021
|
R21
|
NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed) |
| RFA-EY-21-001 |
See Related
|
NEI |
01/15/2021 |
04/02/2021
|
10/28/2023
|
R21
|
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
| RFA-TR-21-010 |
See Related
|
NCATS |
01/13/2021 |
03/13/2021
|
01/13/2022
|
U44
|
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) |
| RFA-DK-21-001 |
See Related
|
NIDDK |
01/13/2021 |
03/22/2021
|
11/04/2021
|
R61/R33
|
Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed) |
| RFA-DK-20-032 |
See Related
|
NIDDK |
01/06/2021 |
05/22/2021
|
06/23/2023
|
R34
|
Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required) |
| RFA-HL-21-014 |
See Related
|
NHLBI |
01/06/2021 |
02/15/2021
|
10/16/2021
|
R01
|
Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional) |
| RFA-CA-21-019 |
See Related
|
NCI |
12/02/2020 |
05/09/2021
|
11/19/2021
|
U24
|
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) |
| RFA-CA-21-018 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
U01
|
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) |
| RFA-CA-21-017 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
R01
|
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) |
| RFA-CA-21-016 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
U24
|
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
| RFA-CA-21-015 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
U24
|
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
| RFA-CA-21-014 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
U01
|
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
| RFA-CA-21-013 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
R21
|
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
| RFA-CA-21-008 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
U01
|
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
| RFA-CA-21-009 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
U54
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) |
| RFA-CA-21-010 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
U2C
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
| RFA-CA-21-011 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
P01
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
| RFA-CA-21-012 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
P50
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
| RFA-CA-21-007 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
R01
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
| RFA-CA-21-006 |
See Related
|
NCI |
11/20/2020 |
01/22/2021
|
09/30/2021
|
R33
|
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
| RFA-CA-21-005 |
See Related
|
NCI |
11/20/2020 |
01/22/2021
|
09/30/2021
|
R21
|
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) |
| RFA-CA-21-004 |
See Related
|
NCI |
11/20/2020 |
01/22/2021
|
09/29/2021
|
R33
|
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
| RFA-CA-21-003 |
See Related
|
NCI |
11/20/2020 |
01/22/2021
|
09/30/2021
|
R21
|
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) |
| RFA-ES-21-001 |
See Related
|
NIEHS |
11/19/2020 |
01/26/2021
|
02/25/2023
|
R01
|
Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional) |
| RFA-HD-22-003 |
See Related
|
NICHD |
11/19/2020 |
02/28/2021
|
11/30/2021
|
P50
|
Contraceptive Development Research Centers Program (P50 Clinical Trial Optional) |
| RFA-MH-21-112 |
See Related
|
NIMH |
11/13/2020 |
01/18/2021
|
06/16/2022
|
R43/R44
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) |
| RFA-MH-21-111 |
See Related
|
NIMH |
11/13/2020 |
01/18/2021
|
06/16/2022
|
R34
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) |
| RFA-MH-21-110 |
See Related
|
NIMH |
11/13/2020 |
01/18/2021
|
06/16/2022
|
R01
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) |
| RFA-MH-21-140 |
See Related
|
NIMH |
10/21/2020 |
02/10/2021
|
03/11/2022
|
R01
|
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) |
| RFA-AI-20-076 |
See Related
|
NIAID |
10/20/2020 |
02/17/2021
|
03/18/2023
|
R01
|
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) |
| RFA-DK-20-020 |
See Related
|
NIDDK |
10/19/2020 |
11/22/2020
|
11/10/2022
|
R25
|
NIDDK Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) - Generated Resources (R25 Clinical Trial Not Allowed) |
| RFA-MH-20-620 |
See Related
|
NIMH |
09/25/2020 |
11/07/2020
|
12/10/2022
|
F32
|
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
| RFA-HL-21-018 |
See Related
|
NHLBI |
09/24/2020 |
12/11/2020
|
12/15/2021
|
R01
|
Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed) |
| RFA-CA-20-046 |
See Related
|
NCI |
09/23/2020 |
11/13/2020
|
12/15/2021
|
R01
|
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) |
| RFA-DC-20-002 |
See Related
|
NIDCD |
09/22/2020 |
09/23/2020
|
06/14/2023
|
R25
|
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) |
| RFA-MH-20-556 |
See Related
|
NIMH |
09/17/2020 |
01/11/2021
|
10/20/2021
|
U01
|
BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed) |
| RFA-NS-21-010 |
See Related
|
NINDS |
09/16/2020 |
10/18/2020
|
09/08/2022
|
UG3/UH3
|
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |
| RFA-CA-20-051 |
See Related
|
NCI |
09/15/2020 |
02/15/2021
|
01/19/2022
|
R01
|
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) |
| RFA-DK-20-023 |
See Related
|
NIDDK |
09/01/2020 |
02/03/2021
|
11/18/2021
|
R01
|
Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional) |
| RFA-DK-20-022 |
See Related
|
NIDDK |
08/24/2020 |
02/03/2021
|
11/18/2021
|
R01
|
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) |
| RFA-AG-21-021 |
See Related
|
NIA |
08/13/2020 |
01/03/2021
|
10/22/2022
|
K76
|
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) |
| RFA-AG-21-020 |
See Related
|
NIA |
08/13/2020 |
01/03/2021
|
10/22/2022
|
K76
|
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) |
| RFA-MH-20-600 |
See Related
|
NIMH |
08/07/2020 |
06/14/2021
|
07/15/2023
|
R24
|
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) |
| RFA-ES-20-015 |
See Related
|
NIEHS |
07/20/2020 |
10/30/2020
|
11/29/2022
|
R25
|
NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed) |
| RFA-DA-21-006 |
See Related
|
NIDA |
07/17/2020 |
09/15/2020
|
10/15/2022
|
U01
|
BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed) |
| RFA-NS-21-001 |
See Related
|
NINDS |
07/15/2020 |
08/28/2020
|
09/27/2022
|
P50
|
NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional) |
| RFA-EB-20-002 |
See Related
|
NIBIB |
06/29/2020 |
08/14/2020
|
09/15/2021
|
R01
|
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) |
| RFA-EB-20-001 |
See Related
|
NIBIB |
06/29/2020 |
08/03/2020
|
09/04/2021
|
R01
|
BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed) |
| RFA-HG-20-037 |
See Related
|
NHGRI |
06/04/2020 |
07/03/2020
|
03/14/2023
|
R21
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R21) |
| RFA-HG-20-036 |
See Related
|
NHGRI |
06/04/2020 |
07/03/2020
|
03/14/2023
|
R01
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R01) |
| RFA-HL-21-013 |
See Related
|
NHLBI |
04/30/2020 |
06/24/2020
|
06/02/2022
|
R61/R33
|
Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required) |
| RFA-MH-20-525 |
See Related
|
NIMH |
04/06/2020 |
05/20/2020
|
06/21/2022
|
R01
|
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) |
| RFA-HG-20-016 |
See Related
|
NHGRI |
03/19/2020 |
05/25/2020
|
02/05/2022
|
R43/R44
|
Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed) |
| RFA-HG-20-015 |
See Related
|
NHGRI |
03/19/2020 |
05/25/2020
|
02/05/2022
|
R21
|
Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed) |
| RFA-HG-20-014 |
See Related
|
NHGRI |
03/19/2020 |
05/25/2020
|
02/05/2022
|
R01
|
Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) |
| RFA-MH-20-128 |
See Related
|
NIMH |
02/24/2020 |
08/03/2020
|
09/03/2021
|
R01
|
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
| RFA-FD-21-001 |
See Related
|
FDA |
02/19/2020 |
08/06/2020
|
10/06/2021
|
R01
|
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required |
| RFA-OD-20-011 |
See Related
|
ODP |
02/07/2020 |
06/08/2020
|
07/11/2022
|
K01
|
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) |
| RFA-OD-20-010 |
See Related
|
ODP |
02/07/2020 |
06/08/2020
|
07/11/2022
|
K99/R00
|
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) |
| RFA-OD-20-009 |
See Related
|
ODP |
02/07/2020 |
06/08/2020
|
07/11/2022
|
K99/R00
|
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) |
| RFA-OD-20-008 |
See Related
|
ODP |
02/07/2020 |
06/08/2020
|
07/11/2022
|
K01
|
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) |
| RFA-ES-20-006 |
See Related
|
NIEHS |
01/28/2020 |
04/18/2020
|
04/15/2022
|
P30
|
Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) |
| RFA-OD-20-002 |
See Related
|
ORIP |
01/08/2020 |
01/20/2020
|
01/08/2023
|
P40
|
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) |
| RFA-NS-20-006 |
See Related
|
NINDS |
01/02/2020 |
02/24/2020
|
10/04/2022
|
R01
|
BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) |
| RFA-OD-20-006 |
See Related
|
NIH |
12/13/2019 |
01/14/2020
|
11/04/2021
|
R03
|
Small Research Grants for Analyses of Down Syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) |
| RFA-OD-20-005 |
See Related
|
NIH |
12/13/2019 |
01/14/2020
|
11/04/2021
|
R01
|
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
| RFA-OD-20-004 |
See Related
|
NIH |
12/13/2019 |
01/14/2020
|
11/04/2021
|
R21
|
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
| RFA-OD-20-003 |
See Related
|
NIH |
12/13/2019 |
01/14/2020
|
11/04/2021
|
R61/R33
|
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) |
| RFA-MH-20-555 |
See Related
|
NIMH |
11/26/2019 |
01/10/2020
|
10/09/2021
|
S10
|
NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) |
| RFA-MH-20-510 |
See Related
|
NIMH |
11/25/2019 |
02/02/2020
|
03/02/2022
|
R01
|
Laboratories to Optimize Digital Health (R01 Clinical Trial Required) |
| RFA-OH-20-003 |
See Related
|
NIOSH |
11/21/2019 |
11/22/2019
|
01/30/2022
|
T03
|
Commercial Fishing Occupational Safety Training Project Grants (T03) |
| RFA-OH-20-002 |
See Related
|
NIOSH |
11/21/2019 |
11/22/2019
|
01/30/2022
|
U01
|
Commercial Fishing Occupational Safety Research Cooperative Agreement (U01) |
| RFA-NS-19-043 |
See Related
|
NINDS |
11/14/2019 |
01/09/2020
|
11/12/2022
|
K99/R00
|
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) |
| RFA-NS-19-044 |
See Related
|
NINDS |
11/14/2019 |
01/10/2020
|
11/12/2022
|
K99/R00
|
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) |
| RFA-TR-20-001 |
See Related
|
NCATS |
10/23/2019 |
01/06/2020
|
10/07/2021
|
R01
|
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional) |
| RFA-HL-20-029 |
See Related
|
NHLBI |
10/17/2019 |
11/02/2019
|
01/11/2022
|
R03
|
Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 - Clinical Trial Optional) |
| RFA-NS-20-011 |
See Related
|
NINDS |
10/04/2019 |
12/08/2019
|
09/09/2022
|
R43/R44
|
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) |
| RFA-NS-20-010 |
See Related
|
NINDS |
10/04/2019 |
12/08/2019
|
09/09/2022
|
R43/R44
|
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) |
| RFA-NS-20-008 |
See Related
|
NINDS |
10/04/2019 |
12/08/2019
|
09/09/2022
|
R41/R42
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) |
| RFA-NS-20-009 |
See Related
|
NINDS |
10/04/2019 |
12/08/2019
|
09/09/2022
|
R41/R42
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
| RFA-OD-19-029 |
See Related
|
ORWH |
09/27/2019 |
10/25/2019
|
11/27/2021
|
R01
|
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) |
| RFA-OD-19-027 |
See Related
|
ORIP |
09/11/2019 |
09/28/2019
|
09/09/2022
|
R24
|
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) |
| RFA-HL-20-006 |
See Related
|
NHLBI |
09/09/2019 |
10/18/2019
|
01/15/2022
|
K38
|
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) |
| RFA-HL-20-028 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R33
|
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) |
| RFA-HL-20-027 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R33
|
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) |
| RFA-HL-20-024 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R61/R33
|
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) |
| RFA-HL-20-023 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R61/R33
|
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) |
| RFA-HL-20-022 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R33
|
Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) |
| RFA-HL-20-021 |
See Related
|
NHLBI |
09/03/2019 |
09/17/2019
|
12/22/2021
|
R61/R33
|
Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) |
| RFA-ES-19-011 |
See Related
|
NIEHS |
07/31/2019 |
10/01/2019
|
10/04/2022
|
R21
|
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) |
| RFA-EB-19-002 |
See Related
|
NIBIB |
06/27/2019 |
08/03/2019
|
09/04/2021
|
U01
|
BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial not allowed) |
| RFA-DA-19-019 |
See Related
|
NIDA |
12/10/2018 |
12/10/2018
|
09/09/2021
|
R43/R44
|
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional) |
| RFA-DA-19-020 |
See Related
|
NIDA |
12/10/2018 |
12/10/2018
|
09/09/2021
|
R41/R42
|
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional) |
| RFA-NS-19-003 |
See Related
|
NINDS |
08/29/2018 |
09/30/2018
|
10/30/2021
|
U19
|
BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed) |
| RFA-NS-19-001 |
See Related
|
NINDS |
08/28/2018 |
10/14/2018
|
10/30/2021
|
U01
|
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required) |
| RFA-FD-18-001 |
See Related
|
FDA |
10/31/2017 |
11/06/2017
|
12/02/2021
|
U18
|
Flexible Funding Model - Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U18) |